Skip to main content Skip to footer

News & Inisghts

Diagnostic Database

Diagnostics 101
Digital Cognitive Assessments
CSF & PET
Blood-Based Biomarkers

Diagnostics 101
Digital Cognitive Assessments
CSF & PET
Blood-Based Biomarkers

News & Inisghts

Diagnostic Database

Diagnostics 101
Digital Cognitive Assessments
CSF & PET
Blood-Based Biomarkers

March 4, 2026|Education, Workgroup Activities

CEOi Webinar in Partnership with ANA

Refining Alzheimer’s disease biological diagnosis with plasma biomarkers: Resolving p-tau217 “gray zone” with p-tau181 integration

Comparative Survey Data (2024 and 2025): Clinician Awareness, Attitudes, and Interest in Blood Tests for Alzheimer’s Disease

Follow Us

Useful Links

Diagnostic Database
Diagnostics 101
Blood-Based Biomarkers
Digital Cognitive Assessments
CSF & PET

support

News & Insights
About Us
Contact Us

© 2026 UsAgainstAlzheimer’s. All rights reserved.

The Global CEO Initiative on Alzheimer’s Disease (CEOi) is a collaboration of leading private sector organizations dedicated to accelerating progress in the fight against Alzheimer's disease. By leveraging the collective influence of its members, CEOi works to shape global dialog, drive innovations in diagnostics and treatment, and increase global awareness of Alzheimer's.

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.